Literature DB >> 25510482

Pulmonary tuberculosis patients with a vitamin D deficiency demonstrate low local expression of the antimicrobial peptide LL-37 but enhanced FoxP3+ regulatory T cells and IgG-secreting cells.

Sayma Rahman1, Anders Rehn1, Jubayer Rahman1, Jan Andersson2, Mattias Svensson1, Susanna Brighenti3.   

Abstract

Control of human tuberculosis (TB) requires induction and maintenance of both macrophage and T cell effector functions. We demonstrate that pulmonary TB patients with a vitamin D deficiency had significantly reduced local levels of the vitamin D-inducible antimicrobial peptide LL-37 in granulomatous lesions compared to distal parenchyma from the infected lung. Instead, TB lesions were abundant in CD3(+) T cells and FoxP3(+) regulatory T cells as well as IgG-secreting CD20(+) B cells, particularly in sputum-smear positive patients with cavitary TB. Mycobacteria-specific serum IgG titers were also elevated in patients with active TB. An up-regulation of the B cell stimulatory cytokine IL-21 correlated with mRNA expression of CD20, total IgG and also IL-10 in the TB lesions. Altogether, vitamin D-deficient TB patients expressed a weak antimicrobial response but an IL-21 associated expansion of IgG-secreting B cells combined with a rise in FoxP3(+) regulatory T cells at the local site of infection.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  Antimicrobial peptide; B cell; Human; Lung; T cell; Tuberculosis

Mesh:

Substances:

Year:  2014        PMID: 25510482     DOI: 10.1016/j.clim.2014.12.003

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  21 in total

Review 1.  Vitamin D Status in South Africa and Tuberculosis.

Authors:  Vanessa Meyer; Tamsyn Jacki Jeffery; Liza Bornman
Journal:  Lung       Date:  2015-08-26       Impact factor: 2.584

2.  Mechanisms of Action of Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia.

Authors:  Guang-Sheng Lei; Chen Zhang; Bi-Hua Cheng; Chao-Hung Lee
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

3.  Prospective study of immunomodulation in osteoarticular tuberculosis non responsive to anti tubercular therapy.

Authors:  B P Sharma; Amit Kumar; Saubhik Das; Shambhu Prasad
Journal:  J Clin Orthop Trauma       Date:  2017-07-03

Review 4.  B in TB: B Cells as Mediators of Clinically Relevant Immune Responses in Tuberculosis.

Authors:  Martin Rao; Davide Valentini; Thomas Poiret; Ernest Dodoo; Shreemanta Parida; Alimuddin Zumla; Susanna Brighenti; Markus Maeurer
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

Review 5.  Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis.

Authors:  Alimuddin Zumla; Martin Rao; Ernest Dodoo; Markus Maeurer
Journal:  BMC Med       Date:  2016-06-15       Impact factor: 8.775

6.  IL-21 signaling is essential for optimal host resistance against Mycobacterium tuberculosis infection.

Authors:  Matthew G Booty; Palmira Barreira-Silva; Stephen M Carpenter; Cláudio Nunes-Alves; Miye K Jacques; Britni L Stowell; Pushpa Jayaraman; Gillian Beamer; Samuel M Behar
Journal:  Sci Rep       Date:  2016-11-07       Impact factor: 4.379

7.  Serum Vitamin D Level as a Risk Factor for Female Genital Tuberculosis (FGTB).

Authors:  Swati Gautam; Amita Jain; Salman Akhtar; Apala Priyadarshini; Shyam Pyari Jaiswar
Journal:  J Clin Diagn Res       Date:  2017-09-01

8.  Hypercalcaemic crisis in an elderly patient with pulmonary tuberculosis.

Authors:  Jason Yongsheng Chan; Mohanaruban Kanthaya
Journal:  Oxf Med Case Reports       Date:  2015-11-03

9.  Short, Synthetic Cationic Peptides Have Antibacterial Activity against Mycobacterium smegmatis by Forming Pores in Membrane and Synergizing with Antibiotics.

Authors:  Kajal Gupta; Sameer Singh; Monique L van Hoek
Journal:  Antibiotics (Basel)       Date:  2015-08-24

Review 10.  The Troika Host-Pathogen-Extrinsic Factors in Tuberculosis: Modulating Inflammation and Clinical Outcomes.

Authors:  Helder Novais Bastos; Nuno S Osório; Sebastien Gagneux; Iñaki Comas; Margarida Saraiva
Journal:  Front Immunol       Date:  2018-01-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.